课题基金 / 基金详情

补体C5a/C5aR通路促pDCs分化和功能形成介导银屑病的机制研究

批准号:
81873881
项目类别:
面上项目
资助金额:
57.0 万元
负责人:
许桂莲
学科分类:
自身免疫性疾病
结题年份:
2022
批准年份:
2018
项目状态:
已结题
项目参与者:
李桂清、李蜀婧、李由、唐铭、何前辉、徐砜

项目摘要

结项摘要

项目成果

许桂莲的其他基金

相似基金

相关文献

中文摘要
银屑病(psoriasis)是一种慢性炎症性皮肤病,涉及遗传和免疫等多种因素,确切的病理机制尚不明确。咪喹莫特(Imiquimod,IMQ)诱导的银屑病皮炎小鼠是研究银屑病最常见的动物模型。利用此模型,在前期研究中我们首次发现,补体C5aR基因缺失可显著衰减小鼠银屑病病情。进一步的研究表明,与C5aR+/+小鼠相比,C5aR-/-小鼠中pDCs (plasmacytoid dendritic cells)的分化和功能均明显受损。新近的文献证实pDCs是导致银屑病免疫病理的关键细胞类型。据此推测:C5a/C5aR通路可能通过促pDCs分化与功能形成来介导银屑病的发生。本研究拟通过体内外实验明确补体C5a/C5aR通路在银屑病免疫病理中的作用;探讨该通路对pDCs分化及功能形成的调控机制。预期结果不但有助于银屑病发病机制的阐明,并且可为临床银屑病有效治疗策略的发展提供重要的理论依据。
英文摘要
Psoriasis is a chronic inflammatory disease of the skin,which is involved in a various factors including genetics and immune system, and there is not an effective treatment strategy for patients with psoriasis. Imiquimod (IMQ)-induced psoriasis dermatitic mice is a now widely accepted animal model in the study about the pathogenesis of psoriasis. In the previous studies, by using this successfully established mice psoriasis model, it was found that, complement C5a receptor (C5aR) gene deficiency significantly attenuated IMQ -induced scaly skin inflammation in mice. Moreover, compared with the wild type mice, both IMQ-induced plasmacytoid dendritic cells (pDCs) infiltration in local skin and the ability of bone marrow cells differentiating into pDCs was remarkably reduced in C5aR KO mice. According to the literatures, pDCs play a critical role during the pathogenesis of psoriasis. We therefore hypothesize that complement C5a/C5aR pathway mediates psoriasis development via the potentiating of pDCs differentiation and functions formation. In the present study, we will define the role of C5a/C5aR pathway in the pathogenesis of psoriasis by combination in vitro with in vivo mice experiments, and then further explore the underlying molecular mechanisms involved in C5a/C5aR pathway regulation in pDCs differentiation and function. Anticipative results will help us further clarify the precise pathogenesis of psoriasis, which may ultimately indicate effective treatment strategies for clinical patients with psoriasis.
银屑病是一种慢性炎症性皮肤病,涉及遗传和免疫等多种因素,确切的病理机制尚不明确。咪喹莫特(Imiquimod,IMQ)涂抹和IL-23皮内注射诱导的银屑病皮炎小鼠是研究银屑病最常见的动物模型。利用此俩模型,我们发现银屑病损皮肤局部补体C5aR1表达增加,C5aR1基因缺陷显著减轻银屑病皮肤炎症,而C5aR拮抗剂阻断C5aR1信号通路后可显著减轻IMQ诱导的银屑病皮肤炎症。基于pDCs是导致银屑病免疫病理的关键细胞类型,我们进一步研究了它们之间的关联,结果发现C5aR1缺乏可显著减少银屑病病灶的pDCs浸润及其功能,体外实验证明C5a可加速骨髓细胞向pDCs的分化以及迁移能力。而且,C5aR1缺乏可显著减少γδ-T细胞IL-17A的产生,并且证实C5a/C5aR1通过PI3K/Akt信号通路促进了IL-17A的产生,C5aR1拮抗剂可降低银屑病样皮炎的发生和T细胞反应,阻断C5aR1可进一步减弱IMQ诱导的IL-17缺陷小鼠的银屑病样皮肤炎症。有趣的是,作为补体C5活化的上游分子,补体 C3缺乏可加重IMQ诱导的银屑病样皮肤炎症;与野生型小鼠相比,C3缺陷小鼠具有相似的IMQ诱导的IL-17A应答,但IFN- gamma应答更强,细胞凋亡增加;Z-VAD-FMK预处理可减轻IMQ诱导的银屑病样皮肤炎症和细胞凋亡,提示补体是一个复杂的网络系统,其内在的关联需进一步阐明。总之,以上结果提示C5a/C5aR1信号通路通过促pDC细胞分化和功能形成,以及上调皮肤炎症γδ-T细胞IL-17A的表达在银屑病的发病机制中发挥关键作用,阻断C5a/C5aR1/IL-17A轴有望成为治疗银屑病的一种有前途的策略。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
Complement component 3 prevents imiquimod-induced psoriatic skin inflammation by inhibiting apoptosis in mice.
补体成分 3 通过抑制小鼠细胞凋亡来预防咪喹莫特诱导的银屑病皮肤炎症。
DOI: 10.1016/j.intimp.2020.106692
发表时间: 2020-06
期刊: International Immunopharmacology
影响因子: 5.6
作者: [Zheng Quan-You, Liang Shen-Ju, Xu Feng, Yang Yi, Feng Jian-Li, Shen Fen, Zhong Yu, Wu Shun, Shu Yong, Sun Dao-Dong, Xu Gui-Lian]
通讯作者: Xu Gui-Lian
DOI: 10.3969/j.issn.1000-484x.2020.08.002
发表时间: 2020
期刊: 中国免疫学杂志
影响因子: --
作者: [徐砜, 郑权友, 李桂清, 陈戬, 许桂莲]
通讯作者: 许桂莲
C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells.
C5a/C5aR1 通过促进 γ δ-T 细胞产生 IL-17A 介导 IMQ 诱导的银屑病皮肤炎症
DOI: 10.1096/fj.202000384r
发表时间: 2020
期刊: The FASEB Journal
影响因子: --
作者: [Zheng Quan-You, Xu Feng, Yang Yi, Sun Dao-Dong, Zhong Yu, Wu Shun, Li Gui-Qing, Gao Wei-Wu, Wang Tao, Xu Gui-Lian, Liang Shen-Ju]
通讯作者: Liang Shen-Ju
C5a/C5aR1 Pathway Is Critical for the Pathogenesis of Psoriasis
C5a/C5aR1 通路对于银屑病的发病机制至关重要
DOI: 10.3389/fimmu.2019.01866
发表时间: 2019-08
期刊: Front Immunol
影响因子: --
作者: [Quan-you Zheng, Shen-ju Liang, Feng Xu, Gui-qing Li, Na Luo, Shun Wu, You Li, Ming Tang, Yu Zhong, Jian Chen, Di Yang, Dao-dong Sun, Ke-qin Zhang, Gui-lian Xu]
通讯作者: Gui-lian Xu
LIGHT-LTβR/HVEM通路在1型糖尿病Tfh细胞分化中的作用机制
补体C5a/C5aR途径促Fgl2表达和C5b-9形成的机制及其在暴发性肝衰竭中的作用
LIGHT-LTβR/HVEM信号通路在Ⅰ型糖尿病β细胞损伤中的作用及机制研究
国内基金
海外基金